← Back to Clinical Trials
Recruiting NCT05320822

NCT05320822 A Pragmatic Rehabilitation Intervention: The Active Rehab Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05320822
Status Recruiting
Phase
Sponsor University of North Carolina, Chapel Hill
Condition Concussion, Brain
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2024-06-04
Primary Completion 2026-09

Trial Parameters

Condition Concussion, Brain
Sponsor University of North Carolina, Chapel Hill
Study Type INTERVENTIONAL
Phase N/A
Enrollment 130
Sex ALL
Min Age 18 Years
Max Age 99 Years
Start Date 2024-06-04
Completion 2026-09
Interventions
Active Rehab (Group 2)Progressive Return to Activity (Group 1)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The strategic objective of this research line is to examine improving short- and long-term outcomes for soldiers following mild traumatic brain injury (mTBI). The technical objectives are to: 1) conduct a Phase 1 quasi-experimental pragmatic trial testing the potential benefit of provider directed active rehabilitation therapies ("Active Rehab") in accelerating return of injured soldiers back to active duty and improving cognitive and functional limitations following mTBI, and 2) operationalize and disseminate a clinical active rehabilitation algorithm for use in military settings. The central hypothesis is that an active rehabilitation algorithm in the context of the progressive return to activity will improve clinical and functional outcomes, including time to return to duty. The Active Rehab intervention expands on progressive return to activity guidelines by providing activities that can be completed and progressed during Stage 1 of the progressive return to activity protocol, when the participant is at least 24 hours postinjury. Active Rehab includes an adaptive paradigm based on personal characteristics, symptom presentation, and duty requirements that integrate with current progressive return to activity guidelines. Activity progressions consider the initial presentation and changes in participant status during treatment, with the goal of safely accelerating recovery. Severity and presence of symptoms will guide progression: worse, same or better as reported by the participant.

Eligibility Criteria

Inclusion Criteria: * Current active duty military personnel stationed at Fort Bragg, North Carolina. * Report to clinic/provider at Fort Bragg and available for recruitment within 2 weeks of mTBI injury date as indicated in medical record. * Initial provider diagnosis of mTBI/concussion within 2 weeks of injury, confirmed via medical record. Exclusion Criteria: * Third mTBI/concussion in the past 12 months as indicated by the medical record and/or participant self-report. * Symptoms clear at rest and exertion within 48 hours as indicated in medical record and or during study enrollment process. * Moderate-Severe TBI, or TBI not meeting the criteria for mTBI as indicated by provider diagnosis. * Polytrauma or other injuries preventing completion of initial study assessments in the 2-week window as indicated in initial screening/medical record. TBI, per the funding opportunity announcement is defined as: "being caused by (1) a direct blow or impact to the head, (2) a penetrating head in

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology